MacroGenics
MGNX
#9183
Rank
โ‚น9.79 B
Marketcap
โ‚น154.77
Share price
-1.73%
Change (1 day)
-35.14%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.55. In 2024 the company made an earnings per share (EPS) of -โ‚น97.41 a decrease over its 2023 EPS that were of -โ‚น13.66.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-94.89%
2024-โ‚น97.41613.33%
2023-โ‚น13.66-92.31%
2022-โ‚น177.53-42.14%
2021-โ‚น306.8136.44%
2020-โ‚น224.87-21.84%
2019-โ‚น287.69-24.58%
2018-โ‚น381.46675.93%
2017-โ‚น49.16-68.05%
2016-โ‚น153.86168.25%
2015-โ‚น57.36-55%
2014-โ‚น127.463400%
2013-โ‚น3.64-108.68%
2012โ‚น41.9724.49%
2011โ‚น33.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น123.82-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,096-46,139.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,305-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น593.59-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น665.21-14,713.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น270.39-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น161.14 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA